Torrent Pharmaceuticals share news, announcements and annual reports
NSE: TORNTPHARMBSE: 500420Pharmaceuticals & BiotechnologyLarge Cap
Torrent Pharmaceuticals Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1994 on BSE, Nov 2002 on NSE
Last close ₹4,580.00up ₹23.00 (0.50%)BSE ₹4,564.10
Share price at the NSE close on 29 Oct 2026. Previous close ₹4,557.00.
29 Oct: open ₹4,540.00, high ₹4,610.90, low ₹4,525.30
52-week range of traded prices to 29 Oct 2026
₹3,532.60Low, 6 Nov 2025₹5,250.00High, 3 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,74,208 Cr61st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 82.02
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.48
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.83%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.76
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,20,05563.1% delivered
Torrent Pharmaceuticals share news and announcements
864 announcements, routine notices left out, newest first. Page 18 of 18.
Oct 2007
12 Oct · Board meeting
To consider, inter alia, Audited Financial Results on Standalone basis and unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on September 30, 2007.
Aug 2007
23 Aug · Meeting
Torrent Pharmaceuticals Ltd. has submitted to the Exchange a copy of the minutes of the proceedings of Annual General Meeting of the Company held on July 31, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2007
31 Jul · Business
Torrent Pharmaceuticals Ltd. has informed the Exchange regarding a press release titled "Torrent Pharma's Q1 net profit up by 65%". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Jul · Board meeting
To consider, inter alia, Audited Financial Results of the Company for the quarter ended on June 30, 2007.10 Jul · Meeting
Torrent Pharmaceuticals Ltd. has submitted to the Exchange a copy of the Notice of the Annual General Meeting of the Members of the Company to be held on July 31, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2007
30 May · Corporate action
Torrent Pharmaceuticals Ltd. has informed the Exchange that the Share Transfer books and Registers of Members of the Company will remain close from June 19, 2007 to June 21, 2007 (both days inclusive) for the purpose of Annual General Meeting.23 May · Business
Torrent Pharmaceuticals Ltd. has informed the Exchange regarding a press release titled "Torrent Pharma's Q4 operating profit Jumps 200%". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 May · Board meeting
To consider, interalia, the Audited Financial Results of the Company for the year ended on March 31, 2007.
Apr 2007
27 Apr · E-mail ID for Investor Complaints
Torrent Pharmaceuticals Ltd. has informed the Exchange that "The Company has created an e-mail ID : investorservices@torrentpharma.com, exclusively for the purpose of registering the complaints by the investors which will be attended by the Compliance Officer of the Company. Further the Company has displayed the above e-mail ID on the Company's Website to facilitate the investors to register their grievances directly to the above e-mail ID to ensure the quick response."27 Apr · Results
Torrent Pharmaceuticals Ltd. has informed the Exchange that the Company shall publish Audited Financial Results within a period of 3 month for the year ended on March 31, 2007 i.e. on or before June 30, 2007.
Mar 2007
19 Mar · Dividend
Torrent Pharmaceuticals Ltd. has informed the Exchange that: "Board of Directors of the Company at their meeting held on March 17, 2007, has declared an Interim Dividend of Rs. 3/- per share on fully paid up equity shares of Rs.5/- each for the year 2006-07. The Interim Dividend will be paid to the eligible members based on the Record Date of March 26, 2007 and the payout of the said Interim Dividend will be on & from March 30, 2007". Further, a copy of the press release, dated March 17, 2007, titled "Torrent Pharma declares Interim Dividend of Rs.3 per share" shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Mar · Board meeting
Inter alia, to consider declaration of Interim Dividend for the year 2006-07. Further, the Company has fixed March 26, 2007 as the Record date for the purpose of payment of said Interim Dividend, if declared and the payout of the said Interim Dividend if declared will be on & from March 30, 2007.
Jan 2007
24 Jan · Business
Torrent Pharmaceuticals Ltd. has informed the Exchange regarding a press release, titled "Torrent Pharma's Q3 Profit Jumps 300%." The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Jan · Board meeting
To consider, inter alia, Audited Financial Results of the Company for the quarter ended on December 31, 2006.